NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
37
BTMD Quote, Financials, Valuation and Earnings
Last price:
$5.87
Seasonality move
:
22.93%
Day range:
$5.70 - $6.15
52-week range:
$3.65 - $8.44
Dividend yield:
0%
P/E ratio:
23.50x
P/S ratio:
1.06x
P/B ratio:
--
Volume:
340.3K
Avg. volume:
187.9K
1-year change:
20.99%
Market cap:
$190.1M
Revenue:
$185.4M
EPS (TTM):
$0.26
Analysts' Opinion
-
Consensus RatingBiote has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Biote has an estimated upside of 62.79% from its current price of $6.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $6.11.
Fair Value
-
According to the consensus of 0 analysts, Biote has 62.79% upside to fair value with a price target of -- per share.
BTMD vs. S&P 500
-
Over the past 5 trading days, Biote has underperformed the S&P 500 by -2.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Biote does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Biote has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Biote reported revenues of $51.4M.
Earnings Growth
-
Biote has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Biote reported earnings per share of $0.33.
Enterprise value:
274.2M
EV / Invested capital:
-34.16x
Price / LTM sales:
1.06x
EV / EBIT:
13.12x
EV / Revenue:
1.42x
PEG ratio (5yr expected):
--
EV / Free cash flow:
8.32x
Price / Operating cash flow:
6.21x
Enterprise value / EBITDA:
11.04x
Gross Profit (TTM):
$135.2M
Return On Assets:
7.62%
Net Income Margin (TTM):
5.2%
Return On Equity:
--
Return On Invested Capital:
28.47%
Operating Margin:
23.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $158M | $184.1M | $193.1M | $45.6M | $51.4M | |
| Gross Profit | $105.3M | $124.8M | $135.2M | $31.4M | $36.2M | |
| Operating Income | -$62.1M | $30.5M | $34.4M | $7.6M | $12.2M | |
| EBITDA | -$986K | $12.2M | $24.8M | $25.5M | $20.2M | |
| Diluted EPS | $1.62 | -$0.22 | $0.26 | $0.24 | $0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $100.8M | $117.8M | $70M | |
| Total Assets | -- | -- | $109.6M | $149.7M | $101.3M | |
| Current Liabilities | -- | -- | $22.4M | $25.1M | $46.5M | |
| Total Liabilities | -- | -- | $219.5M | $201M | $228.1M | |
| Total Equity | -- | -- | -$109.9M | -$51.3M | -$126.8M | |
| Total Debt | -- | -- | $119.7M | $114.2M | $118.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $26M | $39.8M | $160K | $15.6M | |
| Cash From Investing | -- | -$22M | $1.5M | -$484K | -$2M | |
| Cash From Financing | -- | -$15.8M | -$68.7M | -$2.6M | -$1.8M | |
| Free Cash Flow | -- | $24M | $33M | -$324K | $13.6M | |
BTMD
Sector
Market Cap
$190.1M
$43.9M
Price % of 52-Week High
72.39%
45.73%
Dividend Yield
0%
0%
Shareholder Yield
2.69%
-0.74%
1-Year Price Total Return
20.99%
-29.11%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
57.37%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.30
200-day SMA
Sell
Level
$6.21
Bollinger Bands (100)
Buy
Level
5.33 - 6.47
Chaikin Money Flow
Buy
Level
1.9M
20-day SMA
Sell
Level
$6.45
Relative Strength Index (RSI14)
Sell
Level
47.50
ADX Line
Sell
Level
13.78
Williams %R
Neutral
Level
-67.4603
50-day SMA
Buy
Level
$5.88
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
13.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3642)
Sell
CA Score
(Annual)
Level (-3.2745)
Buy
Beneish M-Score
(Annual)
Level (-2.3918)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (4.1974)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
Stock Forecast FAQ
In the current month, BTMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BTMD average analyst price target in the past 3 months is --.
-
Where Will Biote Stock Be In 1 Year?
According to analysts, the consensus estimate is that Biote share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Biote?
Analysts are divided on their view about Biote share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Biote is a Sell and believe this share price will drop from its current level to --.
-
What Is Biote's Price Target?
The price target for Biote over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BTMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Biote is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BTMD?
You can purchase shares of Biote via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Biote shares.
-
What Is The Biote Share Price Today?
Biote was last trading at $5.87 per share. This represents the most recent stock quote for Biote. Yesterday, Biote closed at $6.11 per share.
-
How To Buy Biote Stock Online?
In order to purchase Biote stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 6.77% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 15% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.74% over the past day.
